Around a decade ago, a researcher at the University of Tennessee Graduate School of Medicine (UTSGM) and a graduate student in her lab began to imagine creating a company based on a technology they were developing. In 2022, their initial dream became a reality. They launched Orion Therapeutics, a biotechnology startup company developing next-generation RNA (read more)
Inventions & Patents
UTRF Licensee Veru, Inc. Announces Positive Results of COVID-19 Therapy’s Phase 3 Clinical Study, Seeking Emergency Use Authorization from FDA
UT Research Foundation licensee Veru, Inc. announced on April 11, 2022, that their Phase 3 clinical trial of sabizabulin as an oral therapy for hospitalized severe COVID-19 patients at high risk for Acute Respiratory Distress Syndrome (ARDS) and death showed the drug to be safe and effective. The trial was halted early due to the (read more)
UTRF Inventor Spotlight: Lino Costa & Trevor Moeller
UTSI technology may have a far-reaching impact on the future of micro-satellite space travel Over the last few decades, the field of satellite technology has started to shift toward miniaturization. Instead of satellites the size of cars or school buses, researchers are now creating satellites as small as a Rubik’s® Cube to offer a more (read more)